NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ — Artec Biotech, a company in Rosalind Franklin University’s Helix 51 Incubator, is developing a potentially promising treatment for glioblastoma multiforme (GBM), a deadly cancer for which patients have few if any therapeutic alternatives….